journal article·2024-05-15

Sustained Secretion of CCL21 via an Implantable Cell Reservoir Hydrogel Enhances the Systemic Antitumor Effect of Radiotherapy

Chao Gao, Yuwen Zeng, Linyu Zhang, Jianze Wang, Xiujie Yang, Kui Li, He Ren, Zhaofei Liu

Nano Letters· Volume 24· Issue 19
Publisher page

Abstract

The combination of radiotherapy (RT) and immunotherapy shows promise in improving the clinical treatment of solid tumors; however, it faces challenges of low response rates and systemic toxicity. Herein, an implantable alginate/collagen hydrogel encapsulating C-C motif ligand 21 (CCL21)-expressing dendritic cells (CCL21-DCs@gel) was developed to potentiate the systemic antitumor effects of RT. The hydrogel functioned as a suitable reservoir for in vivo culture and proliferation of CCL21-DCs, thereby enabling sustained CCL21 release. The local CCL21 gradient induced by CCL21-DCs@gel significantly enhanced the efficacy of RT in suppressing primary tumor growth and inhibiting distant metastasis across several mouse models. Furthermore, the combination of RT with CCL21-DCs@gel provided complete prophylactic protection to mice. Mechanistic investigations revealed that CCL21-DCs@gel potentiated RT by promoting tumor lymphangiogenesis and attracting immune cell infiltration into the tumor. Collectively, these results suggest that CCL21-DCs@gel is a promising adjunct to RT for effectively eradicating tumors and preventing tumor recurrence.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Immunotherapy and Immune Responses · Lymphatic System and Diseases · Immune cells in cancer

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Radiation Medicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China

Center for GI Cancer Diagnosis and Treatment, Tumor Immunology and Cytotherapy, Medical Research Center, The Affiliated Hospital of Qingdao University, Qingdao 266003, China

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital and Institute, Beijing 100142, China

Department of Nuclear Medicine, Peking University Third Hospital, Beijing 100191, China

State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing 100191, China

Peking University-Yunnan Baiyao International Medical Research Center, Beijing 100191, China

Funding

National Key Research and Development Program of China · Beijing Municipal Natural Science Foundation · National Natural Science Foundation of China · Beijing Nova Program

References (37)

Show source-provided references
1. 10.1038/nrc.2018.610.1038/nrc.2018.6 ↗
2. 10.1038/s41571-022-00709-y10.1038/s41571-022-00709-y ↗
3. 10.1038/ni.323610.1038/ni.3236 ↗
4. 10.1016/j.ccell.2021.08.00810.1016/j.ccell.2021.08.008 ↗
5. 10.1016/j.trecan.2021.10.00310.1016/j.trecan.2021.10.003 ↗
6. 10.1038/s43018-023-00572-510.1038/s43018-023-00572-5 ↗
7. 10.1172/JCI14518610.1172/JCI145186 ↗
8. 10.1038/s41577-019-0210-z10.1038/s41577-019-0210-z ↗
9. 10.1016/j.it.2016.09.00610.1016/j.it.2016.09.006 ↗
10. 10.3389/fimmu.2017.0022910.3389/fimmu.2017.00229 ↗
11. 10.1016/j.immuni.2021.01.01210.1016/j.immuni.2021.01.012 ↗
12. 10.1038/nri229710.1038/nri2297 ↗
13. 10.1186/s12943-015-0306-410.1186/s12943-015-0306-4 ↗
14. Sharma S. · Int. Trends Immun · 2013 · 1 · 10
15. 10.4049/jimmunol.164.9.455810.4049/jimmunol.164.9.4558 ↗
16. 10.1038/nmat470710.1038/nmat4707 ↗
17. 10.1021/acs.accounts.0c0034110.1021/acs.accounts.0c00341 ↗
18. 10.1038/s41551-021-00831-910.1038/s41551-021-00831-9 ↗
19. 10.1126/scitranslmed.aan448810.1126/scitranslmed.aan4488 ↗
20. 10.1039/C9CS00271E10.1039/C9CS00271E ↗
21. 10.1021/acs.chemrev.0c0117710.1021/acs.chemrev.0c01177 ↗
22. 10.1126/sciadv.adc873810.1126/sciadv.adc8738 ↗
23. 10.1038/nbt.307110.1038/nbt.3071 ↗
24. 10.1038/s41551-021-00712-110.1038/s41551-021-00712-1 ↗
25. 10.3390/polym1311185210.3390/polym13111852 ↗
26. 10.3322/caac.2135810.3322/caac.21358 ↗
27. 10.1038/nri91110.1038/nri911 ↗
28. 10.1172/JCI16106510.1172/JCI161065 ↗
29. 10.1126/scitranslmed.aal471210.1126/scitranslmed.aal4712 ↗
30. 10.1126/sciadv.abe436210.1126/sciadv.abe4362 ↗
31. 10.1038/8464310.1038/84643 ↗
32. 10.1158/0008-5472.CAN-04-457610.1158/0008-5472.CAN-04-4576 ↗
33. 10.1038/sj.onc.120874010.1038/sj.onc.1208740 ↗
34. 10.1186/s12885-015-1109-010.1186/s12885-015-1109-0 ↗
35. 10.1172/JCI15547810.1172/JCI155478 ↗
36. 10.1186/1479-5876-6-3810.1186/1479-5876-6-38 ↗
37. 10.1158/1078-0432.CCR-16-282110.1158/1078-0432.CCR-16-2821 ↗